Video Shorts

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
3 days ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
4 days ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
5 days ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
6 days ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
10 days ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
12 days ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
17 days ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
21 days ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
25 days ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
a month ago

1:01
Market Watch Rx: Merck Joins Top Gainers
a month ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
a month ago
by
Michael Christel(+2 more)

0:34
Takeaways from Day One at Access USA 2026
a month ago
by
Nicholas Jacobus(+1 more)

1:01
Market Watch Rx: Intellia Therapeutics Leads Gainers
a month ago
by
Nicholas Jacobus

1:08
What You Need to Know: MFN, Healthcare Spending, and Compounded Medications
a month ago
by
Mike Hollan

0:42
What Can Help Patient Support Operations?
a month ago
by
Nicholas Jacobus(+1 more)

1:41
2026 Drug Pipeline Report
a month ago
by
Michael Christel

0:51
Measuring Good Patient Access from Bad Patient Access
a month ago
by
Nicholas Jacobus(+1 more)

0:30
Can't Afford Your Meds? Watch This
a month ago
by
Nicholas Jacobus(+1 more)

1:05
Market Watch Rx: Pfizer Joins Top Gainers
a month ago
by
Nicholas Jacobus

1:03
Measuring the AI Bubble
2 months ago
by
Michael Christel(+2 more)

0:59
Market Watch Rx: IQVIA Joins Top Gainers
2 months ago
by
Nicholas Jacobus

0:53
FDA Drops Two-Trial Rule for New Drugs
2 months ago
by
Nicholas Jacobus(+1 more)

0:51
Market Watch Rx: Moderna Remains Amongst Top Gainers
2 months ago
by
Nicholas Jacobus

0:38
Europe’s Innovation Edge?
2 months ago
by
Michael Christel(+1 more)

0:53
Future of Healthcare: Hybrid Drug Payment System
2 months ago
by
Nicholas Jacobus(+1 more)

1:03
Market Watch Rx: Moderna Leads Gainers
2 months ago
by
Nicholas Jacobus

0:53
The State of Pharma TV Advertising
2 months ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: AstraZeneca Among Top Gainers
2 months ago
by
Nicholas Jacobus

1:05
The EQ Imperative for Life Science CEOs
2 months ago
by
Michael Christel(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
FDA Awards Priority Voucher to Compass for Psychedelic Therapy in Treatment-Resistant Depression
2
Regeneron Agrees to Lower Drug Costs for U.S. Patients and Provide Otarmeni for Free
3
Moving Cell and Gene Therapy Towards the Future: Q&A with Maher Masoud
4
How Can Pharma Prices be Reduced for Americans Without Impacting Innovation?
5
